Institutional Value
$269731.4B
Total reported holdings
2026 data Public-data reference. official source
BIO-TECHNE CORP
Open-data reference.
CUSIP: 09073M104 · 36 institutional holders
What the 13F Data Shows for BIO-TECHNE CORP
BIO-TECHNE CORP (CUSIP: 09073M104) appears in the SEC Form 13F filings of 36 institutional investment managers as of the 2025-12-31 quarter. Together these institutions report holding 4,694,296 shares with an aggregate market value of $269731.4B. 13F filings are quarterly disclosures that managers with at least $100 million in qualifying U.S. equity assets must file with the SEC within 45 days of each quarter end, so the holdings shown here are a snapshot of positions as of 2025-12-31 — not live or current holdings.
Looking at concentration, the top five institutional holders of BIO-TECHNE CORP control 91% of the reported institutional shares, which makes ownership highly concentrated — a small number of large funds hold material influence over the tradeable institutional float. In the most recent quarter, 4 institutions initiated brand-new positions, 0 increased existing holdings, 1 trimmed their positions, and 7 exited entirely. Each of these actions is drawn directly from a line in a specific 13F filing that can be verified through SEC EDGAR.
Not investment advice. Every figure on this page is sourced from public SEC Form 13F filings and reflects positions as of the reporting quarter — institutional holdings can change significantly between filing dates, and 13F disclosures omit short positions, cash, non-U.S. holdings, and most derivatives. Nothing here is a recommendation to buy, sell, or hold any security. Verify current figures directly on SEC EDGAR and consult a licensed financial professional before making investment decisions based on institutional ownership data.
$269731.4B
Total Institutional Value
36
Institutional Holders
91%
Top-5 Concentration
4
New Buyers This Q
Ownership Concentration Gauge
How concentrated is institutional ownership of BIO-TECHNE CORP? A higher percentage means fewer institutions control more of the stock.
Expense ratio for BIO-TECHNE CORP — Green ≤ 0.20% (Low Cost), Yellow 0.20–0.75% (Average), Orange 0.75–1.50% (Above Avg), Red ≥ 1.50% (High Cost). Source: SEC EDGAR fund prospectus filings.
Concentration Score
91%
Top-5 holder share
New Buyers
4
Latest quarter activity
Institutional Concentration 91.0%
91% of institutional shares held by top 5
Top 5 institutional holders of BIO-TECHNE CORP — share of total reported institutional value
Top Institutional Holders
| # | Institution | Shares | Value | Ownership % |
|---|---|---|---|---|
| 1 | HAHN CAPITAL MANAGEMENT LLC | 60,042 | $3531.1B | 1.3% |
| 2 | Pacer Advisors, Inc. | 14,547 | $855509.0M | 0.3% |
| 3 | GROUPAMA ASSET MANAGMENT | 4,600 | $270526.0M | 0.1% |
| 4 | MidFirst Bank | 3,795 | $3470.0M | 0.0% |
| 5 | Bell Investment Advisors, Inc | 50 | $2941.0M | 0.0% |
Latest Quarter Activity
New Buyers (4)
HAHN CAPITAL MANAGEMENT LLC $3531.1B
Pacer Advisors, Inc. $855509.0M
GROUPAMA ASSET MANAGMENT $270526.0M
MidFirst Bank $3470.0M
Not Investment Advice: Institutional ownership data from SEC Form 13F filings is historical (reported ~45 days after quarter end). Holdings may have changed significantly. Not investment advice.
Frequently Asked Questions
How many institutional investors hold BIO-TECHNE CORP? ▼
BIO-TECHNE CORP is held by 36 institutional investors according to the latest SEC Form 13F filings. Institutional holders include hedge funds, mutual funds, pension funds, and other large investment managers required to disclose their U.S. equity holdings quarterly.
What is the total institutional ownership value of BIO-TECHNE CORP? ▼
The total reported institutional ownership value of BIO-TECHNE CORP is $269731.4B. This figure reflects the aggregate market value of all shares held by 13F-filing institutions as of their most recent quarterly report to the SEC.
How concentrated is institutional ownership of BIO-TECHNE CORP? ▼
The top 5 institutional holders control 91% of all institutional shares in BIO-TECHNE CORP, making ownership highly concentrated. High concentration means a small number of large funds hold significant influence over the stock.
What recent institutional activity has occurred in BIO-TECHNE CORP? ▼
In the latest quarter, 4 institutions initiated new positions, 7 completely exited, 1 reduced their positions. These changes are reported in SEC Form 13F filings, which are filed within 45 days of quarter end. Note that positions may have changed since the filing date.
Where does BIO-TECHNE CORP institutional ownership data come from? ▼
All institutional ownership data for BIO-TECHNE CORP comes from SEC Form 13F filings, which are mandatory quarterly reports filed by institutional investment managers with at least $100 million in qualifying assets. These filings are public records available through the SEC EDGAR database.
Who is the largest institutional holder of BIO-TECHNE CORP? ▼
The largest institutional holder of BIO-TECHNE CORP is HAHN CAPITAL MANAGEMENT LLC with $3531.1B in reported holdings (60,042 shares). This is based on the most recent 13F filing and positions may have changed since the report date.
Learn More About Institutional Ownership
Explore PlainFundData
Related Financial Data
Data sourced from SEC Form 13F filings via the EDGAR database. Filings reflect positions held as of quarter end and are reported within 45 days.
Related
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainFundData Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from SEC Form 13F filings via EDGAR. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: U.S. Securities and Exchange Commission (SEC) — EDGAR Form 13F-HR institutional holdings filings · 2024 Q4 13F filings disclose long positions of institutional managers with $100M+ AUM, filed quarterly within 45 days of period end. Short positions and certain hedging instruments not disclosed.